$ヒムズ&ハーズヘルス(HIMS.US)$ has added GLP-1 weight-loss injections to its portfolio of products.
The injections will have the same active ingredient as $ノボ・ノルディスク(NVO.US)$ ’s Ozempic and Wegovy.
HIMS stock is up by nearly 100% year-to-date.
Hims & Hers added that it would provide branded GLP-1 injections once supply catches up with demand. In the upcoming months, Hims & Hers will work towards providing access to compounded tirzepatide, whic...